Skip to main content
Top

Current Colorectal Cancer Reports

Issue 4/2017

Content (10 Articles)

Radiation Therapy and Radiation Therapy Innovations in Colorectal Cancer (JY Wo, Section Editor)

Clinical Target Volume Definition in Preoperative Radiotherapy of Rectal Carcinoma: a Systematic Review

Marianna Nuzzo, Amalia Bisceglia, Milena Giordano, Lucia Giaccherini, Alessandra Guido, Gabriella Macchia, Annamaria Vinciguerra, Giovanna Mantello, Giuseppina Sallustio, Savino Cilla, Silvia Cammelli, Francesco Deodato, Milly Buwenge, Domenico Genovesi, Lorenzo Fuccio, Alessio G. Morganti

Radiation Therapy and Radiation Therapy Innovations in Colorectal Cancer (JY Wo, Section Editor)

Biomarkers that Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

Philmo Oh, Kevin L. Du

Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)

Colonoscopy and Flexible Sigmoidoscopy in Colorectal Cancer Screening and Surveillance

Juliana Yang, John H. Kwon

Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)

The Role of CT Colonography as a Screening Tool for Colorectal Cancer

Vasantha Vasan, Cecelia Brewington

Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)

Adenomatous Polyposis Syndromes: Familial Adenomatous Polyposis and MutYH-Associated Polyposis

Jean H. Ashburn, Matthew F. Kalady

Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)

Quality Colorectal Cancer Screening: Endoscopic Performance Measures and Beyond

Matthew A. Mason, Brooks D. Cash

Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)

Colorectal Cancer Surveillance: What Is the Optimal Frequency of Follow-up and Which Tools Best Predict Recurrence?

Michele M. Gage, Matthew T. Hueman

Systemic Therapies in Colorectal Cancer (RD Kim, Section Editor)

Treatment of Refractory Colorectal Cancer: Regorafenib vs. TAS-102

Jae Ho Jeong, Yong Sang Hong, Tae Won Kim

Basic Science Foundations in Colorectal Cancer (J Roper, Section Editor)

Resistance Mechanisms to Colorectal Cancer Therapeutics and the Clinical Implications

Philip Emmerich, Linda Clipson, Dustin A. Deming

Basic Science Foundations in Colorectal Cancer (J Roper, Section Editor)

Inflammation and Colorectal Cancer

Apple G. Long, Emma T. Lundsmith, Kathryn E. Hamilton

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine